Normal values of urinary albumin and total protein excretion during pregnancy

1994 ◽  
Vol 171 (4) ◽  
pp. 984-989 ◽  
Author(s):  
Kenneth Higby ◽  
Cheryl R. Suiter ◽  
John Y. Phelps ◽  
Theresa Siler-Khodr ◽  
Oded Langer
2019 ◽  
Vol 104 (9) ◽  
pp. 4169-4177 ◽  
Author(s):  
Ho Lim Lee ◽  
Meryl A Waldman ◽  
Sungyoung Auh ◽  
James E Balow ◽  
Elaine K Cochran ◽  
...  

Abstract Context Patients with lipodystrophy have high prevalence of proteinuria. Objective To assess kidney disease in patients with generalized (GLD) vs partial lipodystrophy (PLD), and the effects of metreleptin on proteinuria in patients with lipodystrophy. Design, Setting, Patients, Intervention Prospective, open-label studies of metreleptin treatment in patients with GLD and PLD at the National Institutes of Health. Outcome Measures The 24-hour urinary albumin and protein excretion rates, estimated glomerular filtration rate (eGFR), and creatinine clearance (CrCl) were measured at baseline and during up to 24 months of metreleptin treatment. Patients with increases in medications affecting outcome measures were excluded. Results At baseline, patients with GLD had significantly greater albuminuria, proteinuria, eGFR, and CrCl compared with patients with PLD. CrCl was above the normal range in 69% of patients with GLD and 39% with PLD (P = 0.02). With up to 24 months of metreleptin treatment, there were significant reductions in albuminuria and proteinuria in patients with GLD, but not in those with PLD. No changes in eGFR or CrCl were observed in patients with GLD or PLD during metreleptin treatment. Conclusions Patients with GLD had significantly greater proteinuria than those with PLD, which improved with metreleptin treatment. The mechanisms leading to proteinuria in lipodystrophy and improvements in proteinuria with metreleptin are not clear. Hyperfiltration was also more common in GLD vs PLD but did not change with metreleptin.


1975 ◽  
Vol 21 (12) ◽  
pp. 1795-1798 ◽  
Author(s):  
E BenGershôm

Abstract The usefulness of bromcresol green for estimating albumin in urine was evaluated by comparison with the Laurell "rocket" technique. In contrast to the bromcresol green method applied for urinary albumin, rather doubtful results were obtained with conventional (Microzone) electrophoresis for albumin and with precipitation techniques for total protein estimation. Albumin estimation with bromcresol green is recommended as a more reliable substitute for total-protein estimations in urine. Limitations of bromcresol green are also pointed out.


2007 ◽  
Vol 293 (1) ◽  
pp. F100-F109 ◽  
Author(s):  
Yuri Ozawa ◽  
Hiroyuki Kobori

This study was performed to determine the effectiveness of the Rho kinase inhibitor and NF-κB inhibitor in renal injury of ANG II-infused hypertensive rats. Male Sprague-Dawley rats, maintained on a normal diet, received either a sham operation ( n = 7) or continuous ANG II infusion (120 ng/min) subcutaneously via minipumps. The ANG II-infused rats were further subdivided into three subgroups ( n = 7 each) to receive one of the following treatments during the entire period: vehicle, Rho kinase inhibitor (fasudil; 3 mg·kg−1·day−1 ip), or NF-κB inhibitor (parthenolide; 1 mg·kg−1·day−1 ip). After 12 days of ANG II infusion, systolic blood pressure (BP; 208 ± 7 vs. 136 ± 3 mmHg), Rho kinase activity, NF-κB activity, renal ANG II contents (160 ± 25 vs. 84 ± 14 pg/g), monocytic chemotactic protein (MCP) 1 mRNA, interstitial macrophage infiltration, transforming growth factor-β1 (TGF-β1) mRNA, interstitial collagen-positive area, urinary protein excretion (43 ± 6 vs. 11 ± 2 mg/day), and urinary albumin excretion were significantly enhanced compared with the Sham group. While fasudil or parthenolide did not alter systolic BP (222 ± and 190 ± 21, respectively), both treatments completely blocked ANG II-induced enhancement of NF-κB activity, renal ANG II contents (103 ± 11 and 116 ± 21 pg/g, respectively), MCP1 mRNA, interstitial macrophage infiltration, TGF-β1 mRNA, interstitial collagen-positive area, urinary protein excretion (28 ± 6 and 23 ± 3 mg/day, respectively), and urinary albumin excretion. Importantly, parthenolide did not alter ANG II-induced Rho kinase activation although fasudil abolished ANG II-induced Rho kinase activation. These data indicate that the Rho-NF-κB axis plays crucial roles in the development of ANG IIinduced renal injury independently from BP regulation.


2011 ◽  
Vol 57 (1) ◽  
pp. 21-28 ◽  
Author(s):  
Shona Methven ◽  
Mark S. MacGregor ◽  
Jamie P. Traynor ◽  
Mario Hair ◽  
Denis St J. O'Reilly ◽  
...  

2011 ◽  
Vol 27 (4) ◽  
pp. 1534-1541 ◽  
Author(s):  
Edward R. Smith ◽  
Michael M. X. Cai ◽  
Lawrence P. McMahon ◽  
David A. Wright ◽  
Stephen G. Holt

1963 ◽  
Vol 86 (2) ◽  
pp. 241-244 ◽  
Author(s):  
Robert H. Glass ◽  
Claes Risinger ◽  
Leif Wide ◽  
Carl A. Gemzell

Author(s):  
Peter G Shakespeare ◽  
Edward J Coombes ◽  
Joan Hambleton ◽  
Diane Furness

Qualitative and quantitative aspects of the excretion of protein after burn injury have been investigated. The excretion of total protein and of albumin have been measured nephelometrically while the excretion of proteins of both serum and non-serum origin have been measured by immunoelectrophoresis using antiserum against serum proteins or against a pool of urine from burned patients. Comparison of the patterns of proteins observed in urine using these two different antisera showed the presence of at least three major proteins that did not originate from the plasma. The excretion of two of these three proteins followed closely the pattern of total protein excretion which reached a maximum at five to seven days after injury. The excretion of albumin was greatest in the first 48 hours after injury. Examination of the original burn patients' urine antigen by sodium dodecyl sulphate polyacrylamide gel electrophoresis showed that this urine pool contained greater amounts of lower molecular weight proteins than were observed in a pool of normal urines. The observations suggest that a biphasic renal pathophysiology is observed after burn injury. Initially, there develops a mild transient glomerular lesion which progresses to a different state which shows at least some of the features of a tubular proteinuria.


2021 ◽  
Vol 36 (Supplement_1) ◽  
Author(s):  
Hideaki Kuno ◽  
Go Kanzaki ◽  
Rina Oba ◽  
Saeko Hatanaka ◽  
Takaya Sasaki ◽  
...  

Abstract Background and Aims Lower estimated glomerular filtration rate (eGFR) and higher proteinuria are the most sensitive predictor of the development of progressive renal insufficiency in various glomerular diseases. On the other hand, the onset of idiopathic membranous nephropathy (iMN) shows insidious progression, and the prognosis varies significantly. Therefore, it is difficult to predict the renal outcome in MN, using only the severity of proteinuria. Fractional excretion of total protein (FETP), which was protein clearance divided by creatinine clearance (Ccr), may be a better indicator of protein leak per functioning nephron. A recent study has also reported that FETP accurately predicted transplant failure and was more sensitive and specific than protein creatine ratio (PCR). Few studies, however, have analyzed the FETP to evaluate their relationship with renal function and histologic lesions in glomerular diseases. Thus, this study aims to assess the relationship between FETP and the clinicopathological findings and whether FETP predicts outcome in iMN. Method This study included patients with iMN that underwent kidney biopsies during the period from 2002 to 2020. We analyzed 24-h urinary protein excretion, FETP, and other clinicopathological findings at the kidney biopsy. The FETP was determined by the standard clearance technique based on 24-h urine collection: FETP = (urinary total protein / serum total protein) / (urinary creatinine / serum creatinine) × 100. A 30% decrease in eGFR or the occurrence of ESRD were the endpoints. The multivariate factors affecting the prognosis were analyzed with the Cox proportional-hazards model, and the cumulative risk of risk factors was analyzed by Kaplan‑Meier curve. Results A total of 153 subjects with MN were identified and were followed up for a median of 5.4 years. (age 64.9±13.6 [mean ± SD] years, male 73.2 %, hypertension 42.5 %, diabetes 10.5 %, nephrotic Syndrome 67.3 %, chronic kidney disease [CKD: eGFR<60ml/min/1.73m2] 51.9 %, eGFR 61.6±22.6 mL/min/1.73m2, urinary protein excretion [u-TP] 4.3±3.6 g/day, PCR 5.4±4.5 g/gCr, FETP 0.12±0.18 %, Selectivity Index [S.I] 0.23±0.39, fractional excretion of IgG [FEIgG] 0.065±0.170 %, glomerulosclerosis [GS] 13.9±13.7 %, interstitial fibrosis and tubular atrophy [IFTA] 12.2±10.0 %). FETP was more significantly associated with clinical parameters than PCR and FEIgG (Table.1). The high FETP group had a significantly worse renal prognosis during the follow-up periods than the low FETP group (Figure.1). Using Cox proportional hazards models, with FETP entered, and age, sex, eGFR,u-TP as covariates, FETP predict the primary endpoint with a hazards ratio of 0.343 (P<0.05). Conclusion These results suggest that FETP would be superior to PCR, the standard measure of proteinuria, in predicting outcome in patients with iMN. FETP could indicate the increased glomerular protein permeability and decreased glomerular filtration function in iMN.


Sign in / Sign up

Export Citation Format

Share Document